Plasma Treated MDI Canisters

Plasma Technology from H&T Presspart

H&T Presspart has developed a revolutionary sub-micron plasma technology process for treating the internal surface of metered-dose inhaler canisters.

The H&T Presspart plasma treatment process improves the surface energy properties of an MDI canister, thus helping to prevent the active content of a drug formulation adhering to the canister wall. This ensures that the patient receives the prescribed dose and solves an inherent problem present within many of today’s metered dose inhalers.

There is also the added benefit of enhanced drug stability performance, in formulations where interactions with the aluminium substrate can lead to product degradation and reduced shelf life.

Advantages of H&T Presspart’s plasma treatment for metered dose inhaler canisters:

  • Uses ultra-pure monomers (99.99% purity).
  • No solvents or other waste products produced.
  • No resulting extractable or leachable material.
  • Canisters are cleaned during the plasma process.
  • Surface treatment fully replicates the contours of the canister.
  • Low surface energy polymerised nanolayer for high degree of repellency.
  • Scalable volume process with excellent cycle to cycle repeatability.
  • No need for post treatment baking at high temperature.

Contact us to discuss the options for plasma treatment or to learn more about H&T Presspart’s plasma technology. To see more information on our plasma process, download the information sheet.

MDI canister plasma

MDI cans

About Presspart

About Presspart Drawing on 42 years of success, Presspart Manufacturing Ltd has developed in to a World-leader of bespoke deep-drawn and injection moulded components, with manufacturing plants located across the Globe. Presspart's ability to offer customers a unique service in toolmaking, design and development skills has been the foundation for more than four decades of successful … read more

Inhalation Product Technology Centre from Presspart

Inhalation Product Technology Centre (IPTC)

Inhalation Product Technology Centre (IPTC) from Presspart Supporting the strategic projects of Presspart and our customers Here at Presspart Manufacturing, we have further expanded our research and development capabilities with the introduction of an Inhalation Product Technology Centre (IPTC). As the world’s leading manufacturer of components for metered dose inhalers, including MDI canisters … read more

presspart infographic

What You Need to Know About Asthma (Infographic)

Asthma is one of the most common conditions that affects people in the UK - and we're proud to be a part of the fight against this often debilitating disease. But how widespread is asthma? What are the facts? … read more

MDI Components

RDD Asia Conference 2016

H&T Presspart to be Silver Sponsor for RDD Asia 2016 H&T Presspart, the world’s leading supplier of respiratory drug delivery components, will be an official Silver Sponsor for this year’s RDD Asia conference, held in Goa, India from the 8-11 November 2016. As a Silver Sponsor of the event, H&T Presspart’s brand will be very visible at the conference including acknowledgement at … read more

© Copyright Presspart Manufacturing Ltd. All Rights Reserved | Whitebirk Ind. Est. Blackburn, Lancashire, BB1 5RF United Kingdom Tel: +44 (0)1254 582233 | Site: www.imageworksltd.com
Privacy Policy | Imprint